ホーム › 鎌状赤血球症 › コロンビア特別区 › Washington
Washington、DCにおける鎌状赤血球症の臨床試験
Washingtonとその周辺地域（約30マイル以内）の拠点で、鎌状赤血球症に関する20件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Blood Sampling for Research Related to Sickle Cell Disease
被験者募集中観察研究健康なボランティア歓迎
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
被験者募集中第3相
- Childrens National Hospital, Washington D.C.
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
被験者募集中早期第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
被験者募集中第3相
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
被験者募集中観察研究
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
被験者募集中第1相
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 7マイル先
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
被験者募集中第1/2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
被験者募集中観察研究
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
被験者募集中第2相
- Center for Cancer and Blood Disorders, Bethesda · 7マイル先
Cooperative Assessment of Late Effects for SCD Curative Therapies
被験者募集中観察研究
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
被験者募集中観察研究
- Children's National Hospital (MRD-HCT), Washington D.C.
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
被験者募集中第2相
- Children's National Hospital, Washington D.C.
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
被験者募集中第2相
- Children's National Health System, Washington D.C.
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
被験者募集中第2相
- Children's National Hospital, Washington D.C.
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
被験者募集中
- Children's National Hospital, Washington D.C.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
被験者募集中
- Children's National Hospital, Washington D.C.
他の都市における鎌状赤血球症の試験
- Atlanta, GA22件の研究
- Chicago, IL18件の研究
- Memphis, TN18件の研究
- Philadelphia, PA15件の研究
- Birmingham, AL14件の研究
- New York City, NY13件の研究
- St. Louis, MO12件の研究
- Boston, MA10件の研究
- Durham, NC10件の研究
- Houston, TX10件の研究
- Cincinnati, OH10件の研究
- Greenville, NC9件の研究
Washingtonにおける他の研究
- がん（全種類）58件の研究
- 非小細胞肺癌55件の研究
- 乳がん46件の研究
- 転移性癌43件の研究
- 肺がん41件の研究
- 前立腺がん38件の研究
- 肥満症33件の研究
- 大腸癌29件の研究
- 心血管疾患28件の研究
- 膀胱癌26件の研究
- 急性骨髄性白血病24件の研究
- 卵巣がん23件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。